YARW ▼ -2.8% - Yarrow Bioscience Inc $YARW Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares Yarrow Bioscience announced the completion of its $172.5 million underwritten public offering, including the full exercise of the underwriters' option for additional shares. The stock declined 2.8% today, a typical reaction when newly issued shares dilute existing shareholders' ownership stakes in a company. 14-SEP-2026 04:06 PM ET